scholarly journals High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma

2002 ◽  
Vol 35 (1) ◽  
pp. 49-57 ◽  
Author(s):  
R.C. Baldissera ◽  
J.F.P. Aranha ◽  
G.B. Oliveira ◽  
A.C. Vigorito ◽  
K.A.B. Eid ◽  
...  
Keyword(s):  
Malignant Lymphoma ◽  
Cell Transplantation ◽  
Peripheral Blood ◽  
Progenitor Cell ◽  
Salvage Treatment ◽  
Peripheral Blood Progenitor Cell ◽  
High Dose

Role of Parenteral Nutrition in Cancer Patients Undergoing High-Dose Chemotherapy Followed by Autologous Peripheral Blood Progenitor Cell Transplantation

2005 ◽  
Vol 91 (3) ◽  
pp. 237-240 ◽  
Author(s):  
Alfredo Tartarone ◽  
Jenna Wunder ◽  
Gianpiero Romano ◽  
Raffaele Ardito ◽  
Giovanni lodice ◽  
...  
Keyword(s):  
Parenteral Nutrition ◽  
Cell Transplantation ◽  
Peripheral Blood ◽  
Progenitor Cell ◽  
Autologous Bone Marrow ◽  
High Dose Chemotherapy ◽  
Peripheral Blood Progenitor Cell ◽  
High Dose ◽  
Conditioning Regimens

High-dose chemotherapy followed by autologous bone marrow or peripheral blood progenitor cell transplantation represents a recognized option in the treatment of solid tumors and hematologic diseases. Patients receiving high-dose chemotherapy are traditionally supported with parenteral nutrition with the aim to prevent malnutrition secondary to gastrointestinal toxicity and metabolic alterations induced by the conditioning regimens. Nevertheless, well-defined guidelines for its use in this clinical setting are lacking and there are several areas of controversy.

Sign in / Sign up

Export Citation Format

Share Document